These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
290 related articles for article (PubMed ID: 2570070)
21. Drug accumulation in the presence of the multidrug resistance pump: dissociation between verapamil accumulation and the action of P-glycoprotein. Ayesh S; Litman T; Stein WD Recept Channels; 1997; 5(3-4):175-83. PubMed ID: 9606721 [TBL] [Abstract][Full Text] [Related]
22. Competitive and non-competitive inhibition of the multidrug-resistance-associated P-glycoprotein ATPase--further experimental evidence for a multisite model. Garrigos M; Mir LM; Orlowski S Eur J Biochem; 1997 Mar; 244(2):664-73. PubMed ID: 9119038 [TBL] [Abstract][Full Text] [Related]
23. Effects of carvedilol on MDR1-mediated multidrug resistance: comparison with verapamil. Kakumoto M; Sakaeda T; Takara K; Nakamura T; Kita T; Yagami T; Kobayashi H; Okamura N; Okumura K Cancer Sci; 2003 Jan; 94(1):81-6. PubMed ID: 12708479 [TBL] [Abstract][Full Text] [Related]
24. Inhibition of P-glycoprotein transport function and reversion of MDR1 multidrug resistance by cnidiadin. Barthomeuf C; Grassi J; Demeule M; Fournier C; Boivin D; Béliveau R Cancer Chemother Pharmacol; 2005 Aug; 56(2):173-81. PubMed ID: 15824923 [TBL] [Abstract][Full Text] [Related]
25. Differential modulation of P-glycoprotein transport by protein kinase inhibition. Bates SE; Lee JS; Dickstein B; Spolyar M; Fojo AT Biochemistry; 1993 Sep; 32(35):9156-64. PubMed ID: 7690250 [TBL] [Abstract][Full Text] [Related]
26. Characterization of P-glycoprotein mediated transport of K02, a novel vinylsulfone peptidomimetic cysteine protease inhibitor, across MDR1-MDCK and Caco-2 cell monolayers. Zhang Y; Benet LZ Pharm Res; 1998 Oct; 15(10):1520-4. PubMed ID: 9794492 [TBL] [Abstract][Full Text] [Related]
27. Inhibition of multidrug resistance by adamantylgb3, a globotriaosylceramide analog. De Rosa MF; Ackerley C; Wang B; Ito S; Clarke DM; Lingwood C J Biol Chem; 2008 Feb; 283(8):4501-11. PubMed ID: 18003606 [TBL] [Abstract][Full Text] [Related]
28. Characterization of multidrug resistance P-glycoprotein transport function with an organotechnetium cation. Piwnica-Worms D; Rao VV; Kronauge JF; Croop JM Biochemistry; 1995 Sep; 34(38):12210-20. PubMed ID: 7547962 [TBL] [Abstract][Full Text] [Related]
30. Identification of the synthetic surfactant nonylphenol ethoxylate: a P-glycoprotein substrate in human urine. Charuk MH; Grey AA; Reithmeier RA Am J Physiol; 1998 Jun; 274(6):F1127-39. PubMed ID: 9841506 [TBL] [Abstract][Full Text] [Related]
31. N-(p-azido-3-[125I]iodophenethyl)spiperone binds to specific regions of P-glycoprotein and another multidrug binding protein, spiperophilin, in human neuroblastoma cells. Safa AR; Agresti M; Bryk D; Tamai I Biochemistry; 1994 Jan; 33(1):256-65. PubMed ID: 7904476 [TBL] [Abstract][Full Text] [Related]
32. Differences in the expression of endogenous efflux transporters in MDR1-transfected versus wildtype cell lines affect P-glycoprotein mediated drug transport. Kuteykin-Teplyakov K; Luna-Tortós C; Ambroziak K; Löscher W Br J Pharmacol; 2010 Jul; 160(6):1453-63. PubMed ID: 20590635 [TBL] [Abstract][Full Text] [Related]
33. Kinetic evidence suggesting that the multidrug transporter differentially handles influx and efflux of its substrates. Stein WD; Cardarelli C; Pastan I; Gottesman MM Mol Pharmacol; 1994 Apr; 45(4):763-72. PubMed ID: 7910372 [TBL] [Abstract][Full Text] [Related]
34. Competitive interaction of cyclosporins with the Vinca alkaloid-binding site of P-glycoprotein in multidrug-resistant cells. Tamai I; Safa AR J Biol Chem; 1990 Sep; 265(27):16509-13. PubMed ID: 1975813 [TBL] [Abstract][Full Text] [Related]
35. Drug absorption limited by P-glycoprotein-mediated secretory drug transport in human intestinal epithelial Caco-2 cell layers. Hunter J; Hirst BH; Simmons NL Pharm Res; 1993 May; 10(5):743-9. PubMed ID: 8100632 [TBL] [Abstract][Full Text] [Related]
36. Atorvastatin transport in the Caco-2 cell model: contributions of P-glycoprotein and the proton-monocarboxylic acid co-transporter. Wu X; Whitfield LR; Stewart BH Pharm Res; 2000 Feb; 17(2):209-15. PubMed ID: 10751037 [TBL] [Abstract][Full Text] [Related]
37. Transport and epithelial secretion of the cardiac glycoside, digoxin, by human intestinal epithelial (Caco-2) cells. Cavet ME; West M; Simmons NL Br J Pharmacol; 1996 Jul; 118(6):1389-96. PubMed ID: 8832062 [TBL] [Abstract][Full Text] [Related]
38. Conferone from Ferula schtschurowskiana enhances vinblastine cytotoxicity in MDCK-MDR1 cells by competitively inhibiting P-glycoprotein transport. Barthomeuf C; Demeule M; Grassi J; Saidkhodjaev A; Beliveau R Planta Med; 2006 Jun; 72(7):634-9. PubMed ID: 16739070 [TBL] [Abstract][Full Text] [Related]
39. Effects of alpha-adrenoceptor antagonist doxazosin on MDR1-mediated multidrug resistance and transcellular transport. Takara K; Sakaeda T; Kakumoto M; Tanigawara Y; Kobayashi H; Okumura K; Ohnishi N; Yokoyama T Oncol Res; 2009; 17(11-12):527-33. PubMed ID: 19806783 [TBL] [Abstract][Full Text] [Related]
40. Transport properties of P-glycoprotein in plasma membrane vesicles from multidrug-resistant Chinese hamster ovary cells. Doige CA; Sharom FJ Biochim Biophys Acta; 1992 Aug; 1109(2):161-71. PubMed ID: 1355667 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]